Research into bacteria in the gut reveals how they potentially cause and affect progression of Parkinson’s Date 24 January 2023 Results from a large study show how changes in certain bacteria may play a part in the development and progression of Parkinson’s.
Parkinson’s UK to co-fund a phase 3 stage clinical trial with Cure Parkinson’s Date 10 January 2023 Through the Parkinson’s Virtual Biotech, we’re investing £1.1m to co-fund a study looking at whether a cough medicine, ambroxol, has the potential to slow the progression of Parkinson’s.
More research needed to investigate iron in Parkinson’s Date 12 December 2022 Results from a clinical trial looking at reducing iron levels in the brain have shown no benefit for unmedicated people with Parkinson’s.
Can light help treat Parkinson’s symptoms? Date 28 November 2022 Light therapy as a potential treatment for Parkinson’s hits the headlines. We take a deeper look at what we know about it so far.
Parkinson’s community boosts recruitment to clinical studies Date 16 November 2022 Back in the summer, we called upon the Parkinson’s community to take part in 5 clinical trials that were at a potential risk of closing. Thanks to you, we had an incredible response and want to keep up the momentum of encouraging people to take part in research.
NRG Therapeutics attracts a further £16m to develop treatments that could slow Parkinson's Date 9 November 2022 The biotech company NRG Therapeutics has received a large investment to continue its drug development project into life-changing new treatments.
Next steps for landmark stem cell study approved Date 27 October 2022 An international clinical trial looking at using stem cells to treat Parkinson’s has been granted approval to go ahead initially in Sweden.
We’re partnering with Enterin to develop a potential new treatment for Parkinson’s dementia Date 13 October 2022 We’re investing £2m in Enterin’s phase 2 clinical trial of its drug ENT-01, a potential treatment for Parkinson’s dementia.
Making progress towards a potential new GDNF trial Date 11 October 2022 Over the last 2 years, Vivifi Biotech has made progress towards a trial that aims to overcome the challenges of the last trial. Now, it’s starting work on the final phase of planning.
Ex-international rugby players have an increased risk of developing Parkinson’s Date 6 October 2022 A study following Scottish international rugby players shows they are more likely to develop neurodegenerative conditions compared to the general public.
